Here, we addressed this issue by monitoring and comparing tumor prevalence and tumor features correlated with the actual number of cells carrying an activated Braf mutant allele, primarily targeted to thyroid and lung by the Nkx2-1 promoter, in Nkx2.1-CreERT2;BrafCA/+ mice. This evidence concerns the gene NKX2-1 and neoplasm.